Please ensure Javascript is enabled for purposes of website accessibility


Big things are happening at Ogier. Change is embedded in everything we do. It is redefining our talent, our ways of working, our platforms of delivery, our culture.



We have the expertise to handle the most demanding transactions. Our commercial understanding and experience of working with leading financial institutions, professional advisers and regulatory bodies means we add real value to clients’ businesses.

View all services

Business Services Team

View all Business Services Team


Our sector approach relies on smart collaboration between teams who have a deep understanding of related businesses and industry dynamics. The specific combination of our highly informed experts helps our clients to see around corners.

View all sectors


Ogier provides practical advice on BVI, Cayman Islands, Guernsey, Irish, Jersey and Luxembourg law through our global network of offices across the Asian, Caribbean and European timezones. Ogier is the only firm to advise on this unique combination of laws.

News and insights

Keep up to date with industry insights, analysis and reviews. Find out about the work of our expert teams and subscribe to receive our newsletters straight to your inbox.

Fresh thinking, sharper opinion.

About us

We get straight to the point, managing complexity to get to the essentials. Our global network of offices covers every time zone. 

No Content Set

Ogier advises on the launch of Medicxi III


22 July 2019


Save as PDF

An Ogier team led by Niamh Lalor, head of the firm's Jersey Investment Funds team, has advised life sciences-focused investment firm Medicxi on the launch of Medicxi III.

In a first and final close, Medicxi raised €400 million from more than 40 investors, including a significant number of new institutional limited partners. Medicxi III, which is established as a Jersey Expert Fund, will make equity and equity-related investments primarily in European and Europe-originated life sciences companies targeting primarily pre-clinical and clinical stage private companies. This brings the total amount raised by Medicxi in the last three years to over $1 billion.

Niamh said: "Congratulations to Medicxi on this successful and rapid fund raise. We are delighted to have worked with Medicxi since it completed its spin-out of the life sciences practice from Index Ventures to this, its third generation fund."

The Ogier team, which included managing associate Alexandra O'Grady, worked with lead counsel Travers Smith on the launch.

No Content Set